World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Medicine
USA
2026

D-Index & Metrics

Best Scientists

D-Index
205
Citations
156921
World Ranking
242
National Ranking
161

Medicine

D-Index
210
Citations
162622
World Ranking
135
National Ranking
92

Research.com Recognitions

  • 2026 - Research.com Medicine in United States Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Medicine in United States Leader Award
  • 2023 - Research.com Medicine in United States Leader Award

Overview

John D. Minna is affiliated with The University of Texas Southwestern Medical Center in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a strong focus on Oncology and related subfields.

The scientist's research covers several key areas, including:

  • Lung Cancer Research Studies
  • Cancer Immunotherapy and Biomarkers
  • Neuroendocrine Tumor Research Advances
  • Lung Cancer Treatments and Mutations
  • RNA modifications and cancer
  • Cancer Genomics and Diagnostics
  • Epigenetics and DNA Methylation

Publication venues where John D. Minna has frequently contributed include:

  • Cancer Research
  • Journal of Thoracic Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Cell
  • Translational Lung Cancer Research

The scientist has published several notable papers, such as:

  • Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities, 2021, Cancer Cell
  • Mechanical regulation of glycolysis via cytoskeleton architecture, 2020, Nature
  • Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression, 2021, Science Advances
  • New Approaches to SCLC Therapy: From the Laboratory to the Clinic, 2020, Journal of Thoracic Oncology
  • SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures, 2020, Cell Reports

John D. Minna collaborates regularly with a group of frequent coauthors, including:

  • Luc Girard
  • Ignacio I. Wistuba
  • Ling Cai
  • Boning Gao
  • John V. Heymach

Best Publications

  • Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

    Bernard J. Poiesz;Francis W. Ruscetti;Adi F. Gazdar;Paul A. Bunn

  • Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.

    James Carmichael;William G. DeGraff;Adi F. Gazdar;John D. Minna

  • Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

    Hisayuki Shigematsu;Hisayuki Shigematsu;Li Lin;Takao Takahashi;Masaharu Nomura

  • Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

    Mark G. Kris;Bruce E. Johnson;Lynne D. Berry;David J. Kwiatkowski

  • Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer.

    Frank Cuttitta;Desmond N. Carney;James Mulshine;Terry W. Moody

  • p53: a frequent target for genetic abnormalities in lung cancer

    Takashi Takahashi;Marion M. Nau;Itsuo Chiba;Michael J. Birrer

  • BRAF and RAS mutations in human lung cancer and melanoma

    Marcia S. Brose;Patricia Volpe;Michael Feldman;Madhu Kumar

  • The national lung screening trial: Overview and study design

    Constantine A. Gatsonis;Denise R. Aberle;Christine D. Berg;William C. Black

  • Characterizing the cancer genome in lung adenocarcinoma

    Barbara A. Weir;Barbara A. Weir;Michele S. Woo;Gad Getz;Sven Perner;Sven Perner

  • A small-cell lung cancer genome with complex signatures of tobacco exposure

    Erin D. Pleasance;Philip J. Stephens;Sarah O’Meara;Sarah O’Meara;David J. McBride

  • An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

    Lauren Averett Byers;Lixia Diao;Jing Wang;Pierre Saintigny

  • High-throughput oncogene mutation profiling in human cancer

    Roman K. Thomas;Alissa C. Baker;Ralph M. DeBiasi;Ralph M. DeBiasi;Wendy Winckler;Wendy Winckler

  • Amplification and expression of the c- myc oncogene in human lung cancer cell lines

    Cameron D. Little;Marion M. Nau;Desmond N. Carney;Adi F. Gazdar

  • Abnormalities in Structure and Expression of the Human Retinoblastoma Gene in SCLC

    J. W. Harbour;Shinn Liang Lai;Jacqueline Whang-Peng;Adi F. Gazdar

  • Establishment and Identification of Small Cell Lung Cancer Cell Lines Having Classic and Variant Features

    Desmond N. Carney;Adi F. Gazdar;Gerold Bepler;John G. Guccion

  • Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer

    Charles M Rudin;Steffen Durinck;Eric W Stawiski;John T Poirier

  • SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

    Adam J. Bass;Adam J. Bass;Hideo Watanabe;Hideo Watanabe;Craig H. Mermel;Craig H. Mermel;Soyoung Yu

  • Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression

    David G. Burbee;Eva Forgacs;Sabine Zöchbauer-Müller;Latha Shivakumar

  • Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data.

    Charles M. Rudin;John T. Poirier;Lauren Averett Byers;Caroline Dive

  • Somatic mutations of the HER2 kinase domain in lung adenocarcinomas

    Hisayuki Shigematsu;Hisayuki Shigematsu;Takao Takahashi;Masaharu Nomura;Kuntal Majmudar

Frequent Co-Authors

Adi F. Gazdar
Adi F. Gazdar The University of Texas Southwestern Medical Center
Luc Girard
Luc Girard The University of Texas Southwestern Medical Center
Ignacio I. Wistuba
Ignacio I. Wistuba The University of Texas MD Anderson Cancer Center
John V. Heymach
John V. Heymach The University of Texas MD Anderson Cancer Center
Yang Xie
Yang Xie The University of Texas Southwestern Medical Center
Carmen Behrens
Carmen Behrens The University of Texas MD Anderson Cancer Center
Jack A. Roth
Jack A. Roth The University of Texas MD Anderson Cancer Center
Jerry W. Shay
Jerry W. Shay The University of Texas Southwestern Medical Center
Daniel C. Ihde
Daniel C. Ihde National Institutes of Health
Paul A. Bunn
Paul A. Bunn University of Colorado Boulder

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in healthcare can open doors to rewarding and flexible careers. For those interested in leadership or administrative roles, health administration degrees online offer a convenient way to qualify for positions in management without pausing your career. These programs are designed to build essential skills in healthcare policy, finance, and operations.

Cost is an important consideration for graduate studies. The cost of mha degree programs can vary widely between institutions. Many online options provide greater affordability, allowing students to advance their education while minimizing debt.

Nurses aiming for top clinical roles may consider the most affordable online dnp programs. Earning a Doctor of Nursing Practice (DNP) opens pathways to advanced practice, leadership, and clinical research, often with flexible study schedules.

If pharmacy interests you, online pharmacy schools provide doctorate programs tailored for working professionals. These online options help you prepare for licensure and specialized pharmacy careers while managing work or family obligations.

Best Scientists Citing John D. Minna

Trending Scientists